Neuro-stem cell stimulation and growth enhancement with implantable nanodevice

US10918852B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10918852-B2
Application numberUS-201916573644-A
CountryUS
Kind codeB2
Filing dateSep 17, 2019
Priority dateNov 13, 2017
Publication dateFeb 16, 2021
Grant dateFeb 16, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A nanodevice includes an array of metal nanorods formed on a substrate. An electropolymerized electrical conductor is formed over tops of a portion of the nanorods to form a reservoir between the electropolymerized conductor and the substrate. The electropolymerized conductor includes pores that open or close responsively to electrical signals applied to the nanorods. A cell loading region is disposed in proximity of the reservoir, and the cell loading region is configured to receive stem cells. A neurotrophic dispensing material is loaded in the reservoir to be dispersed in accordance with open pores to affect growth of the stem cells when in vivo.

First claim

Opening claim text (preview).

What is claimed is: 1. A nanodevice, comprising: an electropolymerized electrical conductor formed over tops of nanorods to form a reservoir between the electropolymerized electrical conductor and a substrate, the electropolymerized electrical conductor including pores that open and close responsively to electrical signals applied to the nanorods; a cell loading region configured to receive cells; and a neurotrophic dispensing material loaded in the reservoir, the neurotrophic dispensing material being dispersed when the pores are open to affect growth of the cells when in vivo. 2. The nanodevice as recited in claim 1 , wherein the electropolymerized electrical conductor includes electrically conductive polymers selected from the group consisting of polypyrrole, polyanilines, poly(thiophene), poly(3,4-ethylenedioxythiophene), poly(p-phenylene sulfide), poly(p-phenylene vinylene), poly(acetylene) and a combination thereof. 3. The nanodevice as recited in claim 1 , wherein the substrate includes a semiconductor material and further comprises a control circuit formed in the substrate to control activation of electrodes formed by the nanorods. 4. The nanodevice as recited in claim 1 , wherein the neurotrophic dispensing material includes a neurotrophin selected from the group consisting of brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), neurotrophin-4 (NT-4) and nerve growth factor (NGF). 5. The nanodevice as recited in claim 1 , wherein the electrical signals are pulsed to control an amount of neurotrophic dispensing material released. 6. The nanodevice as recited in claim 1 , wherein the cell loading region is configured to use a gel media to receive the cells. 7. The nanodevice as recited in claim 1 , wherein the cell loading region is configured to use an electrical charge to receive the cells. 8. The nanodevice as recited in claim 1 , wherein the cells are stem cells. 9. The nanodevice as recited in claim 8 , wherein the cells are neuro-stem cells.

Assignees

Inventors

Classifications

  • A61K38/185Primary

    Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3 · CPC title

  • for implantation or insertion into the body, e.g. heart electrode (A61N1/06 takes precedence) · CPC title

  • Arrangements or circuits for monitoring, protecting, controlling or indicating {(for external stimulators A61N1/3603; for implantable neurostimulators A61N1/36128; for heart stimulators A61N1/37; for defibrillators A61N1/3925)} · CPC title

  • A61N1/04Primary

    Electrodes {(electrosurgical electrodes A61B18/14)} · CPC title

  • Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10918852B2 cover?
A nanodevice includes an array of metal nanorods formed on a substrate. An electropolymerized electrical conductor is formed over tops of a portion of the nanorods to form a reservoir between the electropolymerized conductor and the substrate. The electropolymerized conductor includes pores that open or close responsively to electrical signals applied to the nanorods. A cell loading region is d…
Who is the assignee on this patent?
IBM
What technology area does this patent fall under?
Primary CPC classification A61K38/185. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).